Jardiance vs Rybelsus
A side-by-side look at two diabetes medications advertised on TV. Informational only — not medical advice.
Maintained by TVPills Editorial Team · Site updated November 4, 2026 (not a product-label review)
| Attribute | US Jardiance | US Rybelsus |
|---|---|---|
| Generic name | empagliflozin Unverified catalogue summary (Generic name) for Jardiance in US; not checked against current local product information. | semaglutide Unverified catalogue summary (Generic name) for Rybelsus in US; not checked against current local product information. |
| Drug class | See official local label Unverified catalogue summary (Drug class) for Jardiance in US; not checked against current local product information. | See official local label Unverified catalogue summary (Drug class) for Rybelsus in US; not checked against current local product information. |
| Treats | Type 2 diabetes, heart failure, chronic kidney disease Unverified catalogue summary (Treats) for Jardiance in US; not checked against current local product information. | Type 2 diabetes Unverified catalogue summary (Treats) for Rybelsus in US; not checked against current local product information. |
| Category | Diabetes Unverified catalogue summary (Category) for Jardiance in US; not checked against current local product information. | Diabetes Unverified catalogue summary (Category) for Rybelsus in US; not checked against current local product information. |
| Manufacturer | Boehringer Ingelheim Pharmaceuticals, Inc. Unverified catalogue summary (Manufacturer) for Jardiance in US; not checked against current local product information. | Novo Nordisk Unverified catalogue summary (Manufacturer) for Rybelsus in US; not checked against current local product information. |
| Year approved | — Unverified catalogue summary (Year approved) for Jardiance in US; not checked against current local product information. | — Unverified catalogue summary (Year approved) for Rybelsus in US; not checked against current local product information. |
| Catalogue warning level | Safety summary withheld — check official label Unverified catalogue summary (Catalogue warning level) for Jardiance in US; not checked against current local product information. | Safety summary withheld — check official label Unverified catalogue summary (Catalogue warning level) for Rybelsus in US; not checked against current local product information. |
| Est. TV ad spend | $280M | $180M |
| Side effects and serious risks | — Unverified catalogue summary (Side effects and serious risks) for Jardiance in US; not checked against current local product information. | — Unverified catalogue summary (Side effects and serious risks) for Rybelsus in US; not checked against current local product information. |
Jardiance
Sources and editorial standards
Use the current DailyMed labels to verify approved uses, boxed warnings, and side effects for each medication. Label results can differ by product, strength, and formulation.
Page updated November 4, 2026; the linked resources have not necessarily been reviewed on this date.
Frequently asked questions
Is Jardiance or Rybelsus better?
This directory does not compare clinical effectiveness or safety. Listing Jardiance and Rybelsus together does not establish shared approved indications, equivalence or suitability as substitutes. Consult the correct local labels and your prescriber.
What's the difference between Jardiance and Rybelsus?
The table shows catalogue identification and estimated advertising information for Jardiance and Rybelsus, not a verified medical comparison. Medical descriptions, mechanisms and safety summaries are withheld.
Which one spends more on TV ads?
Jardiance has the larger estimated TV advertising budget of the two.